CDK4 and lung cancer: Studies on nonsmall cell lung cancer (NSCLC) have shown that the high expression of YTHDF1 can promote the development of tumors by promoting protein translation of cyclin E-associated kinase 2 (CDK2), cyclin-dependent kinase 4 (CDK4) and cyclin D1 mRNAs.